MedTrace Logo

Bioequivalence Study of Rosuvastatin in Healthy Volunteers Under Fasting Condition

NCT05197517 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-01-20

No results posted yet for this study

Summary

The present study is conducted to evaluate and compare the relative bioavailability for Rosuvastatin in two different products containing 10 mg film coated tablet after single oral administration.

Conditions

  • Bioequivalence

Interventions

DRUG

Rosuvastatin 10 mg

Film Coated Tablets products containing 10 mg Rosuvastatin

Sponsors & Collaborators

  • Future University in Egypt

    collaborator OTHER

  • Rania Mahmoud Mohamed

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-21
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05197517 on ClinicalTrials.gov